Previous studies on peritonitis and myocardial infarction have demonstrated that ANGPTL4 primarily exhibits anti-inflammatory effects by reducing inflammatory cell infiltration and pro-inflammatory cytokine release [44, 45]. This evidence concerns the gene ANGPTL4 and myocardial infarction.